Adherence to diabetes complication screening was below recommended benchmarks for both HIV+DM and DM-controls for annual foot examination (53 vs. 67%, respectively), biennial eye examination (83 vs. 77%, respectively; and annual urinary albumin measurement (77 vs. 67%, respectively). This evidence concerns the gene ALB and diabetes mellitus.